Most Recent

image: Contributors

Contributors

By | December 1, 2012

Meet some of the people featured in the December 2012 issue of The Scientist.

0 Comments

image: Fat's Immune Sentinels

Fat's Immune Sentinels

By | December 1, 2012

Certain immune cells keep adipose tissue in check by helping to define normal and abnormal physiological states.

0 Comments

image: How Plants Feel

How Plants Feel

By | December 1, 2012

A hormone called jasmonate mediates plants' responses to touch and can boost defenses against pests.

1 Comment

image: In the Long Run

In the Long Run

By | December 1, 2012

Can emulating our early human ancestors make us healthier?

1 Comment

image: Microchannel Masterpiece

Microchannel Masterpiece

By | December 1, 2012

A precision microfluidic system enables single-cell analysis of growth and division.

0 Comments

image: Waking Cancer Cells

Waking Cancer Cells

By | December 1, 2012

A protein called Coco rouses dormant breast cancer cells in the lung.

0 Comments

image: Can Worms Alleviate Autism?

Can Worms Alleviate Autism?

By | November 27, 2012

Autism researchers are testing the ability of whipworm eggs to treat autism in a new clinical trial.

10 Comments

image: Architecture Reveals Genome’s Secrets

Architecture Reveals Genome’s Secrets

By | November 25, 2012

Three-dimensional genome maps are leading to a deeper understanding of how the genome’s form influences its function.

4 Comments

image: Nose Cells Help Paralyzed Dogs

Nose Cells Help Paralyzed Dogs

By | November 20, 2012

A transplant of cells from the lining of the nose helps dogs with spinal injuries walk again.

1 Comment

image: Chimp Patents Challenged

Chimp Patents Challenged

By | November 16, 2012

Three patents on transgenic apes in the European Union will be challenged by animal rights activists.

1 Comment

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham